Neutrophilia, lymphopenia and myeloid dysfunction: A living review of the quantitative changes to innate and adaptive immune cells which define COVID-19 pathology

Codd, Amy S., Hanna, Stephanie J., Compeer, Ewoud B., Richter, Felix C., Pring, Eleanor J., Gea-Mallorquí, Ester, Borsa, Mariana, Moon, Owen R., Scourfield, D. Oliver, Gallimore, Awen M. ORCID: https://orcid.org/0000-0001-6675-7004 and Milicic, Anita 2021. Neutrophilia, lymphopenia and myeloid dysfunction: A living review of the quantitative changes to innate and adaptive immune cells which define COVID-19 pathology. Oxford Open Immunology 2 (1) , iqab016. 10.1093/oxfimm/iqab016

Preview

PDF - Published Version Available under License Creative Commons Attribution. Download (766kB) | Preview

Abstract

Destabilisation of balanced immune cell numbers and frequencies is a common feature of viral infections. This occurs due to, and further enhances, viral immune evasion and survival. Since the discovery of the Severe Acute Respiratory Syndrome coronavirus 2 (SARS-CoV-2), which manifests in coronavirus disease 2019 (COVID-19), a great number of studies have described the association between this virus and pathologically increased or decreased immune cell counts. In this review, we consider the absolute and relative changes to innate and adaptive immune cell numbers, in COVID-19. In severe disease particularly, neutrophils are increased, which can lead to inflammation and tissue damage. Dysregulation of other granulocytes, basophils, and eosinophils represent an unusual COVID-19 phenomenon. Contrastingly, the impact on the different types of monocytes leans more strongly to an altered phenotype, e.g. HLA-DR expression, rather than numerical changes. However, it is the adaptive immune response which bears the most profound impact of SARS-CoV-2 infection. T cell lymphopenia correlates with increased risk of ICU admission and death; therefore, this parameter is particularly important for clinical decision making. Mild and severe disease differ in the rate of immune cell counts returning to normal levels post disease. Tracking the recovery trajectories of various immune cell counts may also have implications for long-term COVID-19 monitoring. This review represents a snapshot of our current knowledge, showing that much has been achieved in a short period of time. Alterations in counts of distinct immune cells represent an accessible metric to inform patient care decision or predict disease outcomes.

Item Type:	Article
Date Type:	Publication
Status:	Published
Schools:	Medicine
Additional Information:	This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/)
Publisher:	Oxford University Press
ISSN:	2633-6960
Date of First Compliant Deposit:	13 September 2021
Date of Acceptance:	1 July 2021
Last Modified:	15 Jun 2023 20:51
URI:	https://orca.cardiff.ac.uk/id/eprint/143997

Actions (repository staff only)

Edit Item